Level 2: Connection with Others

 

Level 2 is based on the understanding that connection with others lies at the heart of healing. The poet John Donne famously said, “No man is an island.” This is especially true when dealing with cancer.

Numerous medical studies demonstrate that social isolation can have adverse effects on all health conditions. A variety of different mechanisms have been proposed as contributing to these increased risks. A universal response to stress, however, is to seek comfort through connection with others. As humans, it is part of our genetic and cultural inheritance.

Over the past 2 decades, a growing body of evidence has documented the value and benefits of connection with others for cancer patients, and loved ones as well. The simple act of sharing with others who are facing similar challenges, in a variety of settings, can greatly improve quality of life. Group members consistently report enhanced well-being and a decrease in anxiety, depression, and feelings of isolation.

Studies also show a decrease in patient’s pain and treatment side effects after participating in support groups. Biologic studies demonstrate that participation in a support group can result in an increase in various immune-system functions, including natural killer cell activity. Several studies have suggested that participation in support programs may even increase overall survival; these results, however, remain controversial.

For a variety of reasons, many patients and/or family members resist participating in formal support groups. Their needs and wishes should be respected. However, there are numerous other avenues that can provide patients with meaningful support, including: religious groups, clergy, clubs and organizations, family, and friends. For many people, the best approach is to gather support from a combination of sources and explore them as fully as possible.

Take action: see How You Can Accomplish Level 2 Today.

Subscribe to Seven Levels of Healing® eNewsletter

< Previous Level   7 Levels Overview Page    Next Level>
Latest Cancer News
ACOG Updates Cervical Cancer Screening Guidelines

November 20, 2009 — The American College of Obstetricians and Gynecologists (ACOG) has revised its cervical cancer screening recommendations: the organization now recommends that women begin screening at the age of 21 and receive screening at less frequent intervals. These recommendations will be published in the December 2009 issue of Obstetrics and Gynecology.

New Velcade®-melphalan Transplant Regimen for Multiple Myeloma

November 20, 2009 — Researchers from France have reported encouraging results with adding Velcade® (bortezomib) to high-dose melphalan followed by autologus stem cell infusion for initial treatment of patients with newly diagnosed multiple myeloma. The details of this Phase II study appeared in an early online publication in Blood on November 2, 2009.

Folic Acid May Be Beneficial in Patients with Recurrent Colorectal Adenoma Who Are Folate Deficient

November 20, 2009 — Researchers affiliated with the Health Professional Follow-Up Study and the Nurses’ Health Study have reported that folic acid supplementation in patients with recurrent colorectal adenoma was not protective or harmful in most patients. However, patients who were folate deficient had a significant 39% decrease in adenoma recurrence. The details of this study appeared in an early online publication on October 28, 2009 in the American Journal of Clinical Nutrition.

Select news items provided by Reuters Health